Veterinary Medicines

Veloxa Chewable Tablets for Dogs

Authorised
  • Praziquantel
  • Pyrantel
  • Febantel
Download as PDF

Product identification

Medicine name:
Veloxa Chewable Tablets for Dogs
Anthelmex Kautabletten für Hunde
Active substance:
  • Praziquantel
  • Pyrantel
  • Febantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 52 blister strips of 2 chewable tablets (104 chewable tablets)
  • PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 13 blister strips of 8 chewable tablets (104 chewable tablets)
  • PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 1 blister strip of 2 chewable tablets (2 chewable tablets)
  • PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 2 blister strips of 2 chewable tablets (4 chewable tablets)
  • PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 1 blister strips of 8 chewable tablets (8 chewable tablets)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Pharmaceuticals Ltd.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401797.00.00
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0116/001
Concerned member states:
  • Austria
  • Belgium
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."